Cargando…
NGMA-3. Use of multi-omics data to initialize and validate a causal model of glioblastoma stem cell signaling
Glioblastomas and glioblastoma stem cells are heterogeneous with respect to mutations, gene expression, and response to drugs. To make predictive responses of individual GBM stem cell lines to drugs, we have constructed a causal model of glioblastoma stem cell signaling. The core model was built sta...
Autores principales: | Holtzapple, Emilee, Miskov-Zivanov, Natasa, Cochran, Brent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255434/ http://dx.doi.org/10.1093/noajnl/vdab070.018 |
Ejemplares similares
-
FLUTE: Fast and reliable knowledge retrieval from biomedical literature
por: Holtzapple, Emilee, et al.
Publicado: (2020) -
NGMA-6. Quantitative MGMT Promoter Methylation Index Indicates Non-Linear, Prognostic Effect in Glioblastoma
por: Gibson, David, et al.
Publicado: (2021) -
NGMA-1. Quantification of IDH mutant alleles predicts outcome in diffuse gliomas
por: Voisin, Mathew, et al.
Publicado: (2021) -
NGMA-2. Dual sgRNA-directed PD-L1 knockout in human glioblastoma cells using the CRISPR/Cas9 system
por: Fierro, Javier, et al.
Publicado: (2021) -
NGMA-5. An in vivo functional genomics screen to identify novel drivers of lung-to-brain metastasis
por: Aghaei, Nikoo, et al.
Publicado: (2021)